Consilio Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$346K Buy
2,878
+81
+3% +$9.35K 0.1% 63
2025
Q4
$294K Buy
2,797
+216
+8% +$20.3K 0.09% 72
2025
Q3
$217K Buy
+2,581
New +$213K 0.07% 89
2025
Q1
Sell
-2,259
Closed -$225K 78
2024
Q4
$225K Sell
2,259
-201
-8% -$20.7K 0.09% 60
2024
Q3
$279K Buy
2,460
+210
+9% +$24.9K 0.12% 54
2024
Q2
$280K Buy
2,250
+105
+5% +$13.5K 0.13% 48
2024
Q1
$283K Buy
+2,145
New +$264K 0.13% 50

Other funds holding MRK

Consilio Wealth Advisors's MRK Position: Q1 2026 in Review

Consilio Wealth Advisors increased its Merck (MRK) stake by 2.9% in Q1 2026, buying an estimated $9.35K and bringing the position to 2,878 shares worth $346K. The position accounts for 0.1% of the portfolio, ranked #63.

Consilio Wealth Advisors first reported a position in MRK in Q1 2024 and has held it in 7 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Consilio Wealth Advisors held 2,878 shares of Merck worth $346K as of Q1 2026.
  • Consilio Wealth Advisors bought 81 Merck shares in Q1 2026, an estimated $9.35K.
  • Merck made up 0.1% of Consilio Wealth Advisors's portfolio in Q1 2026, its #63 holding.
  • Consilio Wealth Advisors first reported a position in Merck in Q1 2024 and has held it in 7 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Consilio Wealth Advisors's 13F filing for Q1 2026, filed 4 May 2026.